Hepatitis C — GS-7977 With Ribavirin for Hepatitis C (SPARE)
Citation(s)
A Randomized Controlled Study To Assess Safety, Tolerability And Efficacy Of GS-7977 In Combination With Full or Low Dose RBV In HCV Genotype 1, Monoinfected Treatment Naive Participants